Systems | Development | Analytics | API | Testing

I am so pleased to announce that Talend has acquired Gamma Soft, a change data capture market innovator. This is a significant enhancement in the capabilities Talend can provide its customers and partners. Talend’s company vision is to take the work out of working with data, and we're thrilled to add Gamma Soft’s technology to our offerings to do this. Change data capture (CDC) technology is highly sought after by many companies.

Greek philosopher Heraclitus wasn’t talking about the challenge of today’s enterprise IT landscape but the quote certainly fits. From the advent of the first digital computer in the 1940s to the emergence of first public cloud in 2004, the rate of change has only accelerated. In fact, over 60% of corporate data resides in the cloud in 2022, up from 50% last year.

Vaccine development became the top priority for the life sciences industry – delivering new vaccines at unprecedented speed and maneuvering large-scale production processes. Numerous factors helped accelerate the vaccine roll-out including prior research, genome sequencing, jumping the FDA approval queue and a plethora of testing volunteers. So now that we’ve experienced these advancements, how can the industry keep momentum to speed-up innovative solutions across healthcare?

A global leader in pharmaceuticals found themselves faced with a unique spin on a common challenge: Their biopharmaceutical division — responsible for producing vaccines and generating over $1 billion in annual sales — was struggling to turn raw data into trusted insights. Data underlies everything the global pharmaceutical company does, however, without data they can trust, they would be at risk of taking longer to get vaccines to market and incurring higher expenses along the way.